aspartic acid has been researched along with arecoline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Expósito, I; Mora, F; Sanz, B | 1 |
| Jaen, JC; Mirzadegan, T; Moreland, D; Schwarz, RD; Spencer, CJ; Tecle, H; Thomas, AJ | 1 |
3 other study(ies) available for aspartic acid and arecoline
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
M1 muscarinic receptor stimulation decreases aspartate release in the rat neostriatum.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Arecoline; Aspartic Acid; Chemotherapy, Cancer, Regional Perfusion; Extracellular Space; Glutamic Acid; Injections, Intraperitoneal; Male; Neostriatum; Oxotremorine; Rats; Rats, Wistar; Receptor, Muscarinic M1; Receptors, Muscarinic | 1997 |
Mutations of aspartate 103 in the Hm2 receptor and alterations in receptor binding properties of muscarinic agonists.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Alanine; Amino Acid Substitution; Animals; Arecoline; Asparagine; Aspartic Acid; Carbachol; COS Cells; Muscarinic Agonists; Mutagenesis, Site-Directed; Oxotremorine; Pilocarpine; Receptor, Muscarinic M2; Receptors, Muscarinic; Transfection | 1995 |